J Melia

Summary

Affiliation: Institute of Cancer Research
Country: UK

Publications

  1. doi request reprint Effects of a prostate awareness pilot on GP consultations and PSA requests
    Jane Melia
    Cancer Screening Evaluation Unit, Institute of Cancer Research, Cotswold Road, Sutton, Surrey, UK
    Fam Pract 27:69-76. 2010
  2. ncbi request reprint A UK-based investigation of inter- and intra-observer reproducibility of Gleason grading of prostatic biopsies
    J Melia
    Department of Histopathology, Addenbrooke s Hospital, Cambridge, UK
    Histopathology 48:644-54. 2006
  3. pmc Urological referral of asymptomatic men in general practice in England
    J Melia
    Cancer Screening Evaluation Unit, Section of Epidemiology, Institute of Cancer Research, Sir Richard Doll Building, Cotswold Road, Sutton, Surrey SM2 5NG, UK
    Br J Cancer 98:1176-81. 2008
  4. pmc The feasibility and results of a population-based approach to evaluating prostate-specific antigen screening for prostate cancer in men with a raised familial risk
    J Melia
    Cancer Screening Evaluation Unit, Institute of Cancer Research, Brookes Lawley Building, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK
    Br J Cancer 94:499-506. 2006
  5. ncbi request reprint Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study
    Jane Melia
    Cancer Screening Evaluation Unit, Institute of Cancer Research, Sutton, Surrey, UK
    BJU Int 94:51-6. 2004
  6. pmc Feasibility of familial PSA screening: psychosocial issues and screening adherence
    J Sweetman
    Academic Department of Radiotherapy, Institute of Cancer Research and Royal Marsden NHS Trust, Downs Road, Sutton, Surrey SM2 5PT, UK
    Br J Cancer 94:507-12. 2006
  7. ncbi request reprint Evaluation of primary prevention initiatives for skin cancer: a review from a UK perspective
    J Melia
    Cancer Screening Evaluation Unit, Section of Epidemiology, D Block, Cotswold Road, Sutton, Surrey SM2 5NG, UK
    Br J Dermatol 143:701-8. 2000
  8. pmc Problems with registration of cutaneous malignant melanoma in England
    J Melia
    Cancer Screening Evaluation Unit, Institute of Cancer Research, Sutton, Surrey, UK
    Br J Cancer 72:224-8. 1995
  9. pmc Evaluation of bowel cancer registration data in England, 1996-2004
    A M Jones
    Cancer Screening Evaluation Unit, Institute of Cancer Research, Sutton, Surrey, UK
    Br J Cancer 101:1269-73. 2009
  10. pmc Feasibility of targeted early detection for melanoma: a population-based screening study
    J Melia
    Cancer Screening Evaluation Unit, Section of Epidemiology, Sutton, Surrey, UK
    Br J Cancer 82:1605-9. 2000

Detail Information

Publications18

  1. doi request reprint Effects of a prostate awareness pilot on GP consultations and PSA requests
    Jane Melia
    Cancer Screening Evaluation Unit, Institute of Cancer Research, Cotswold Road, Sutton, Surrey, UK
    Fam Pract 27:69-76. 2010
    ..Qualitative evaluation showed a wide distribution of materials...
  2. ncbi request reprint A UK-based investigation of inter- and intra-observer reproducibility of Gleason grading of prostatic biopsies
    J Melia
    Department of Histopathology, Addenbrooke s Hospital, Cambridge, UK
    Histopathology 48:644-54. 2006
    ..Gleason score has important implications for patient management but morphological reproducibility data for British practice are limited. Using literature-based criteria nine uropathologists took part in a reproducibility study...
  3. pmc Urological referral of asymptomatic men in general practice in England
    J Melia
    Cancer Screening Evaluation Unit, Section of Epidemiology, Institute of Cancer Research, Sir Richard Doll Building, Cotswold Road, Sutton, Surrey SM2 5NG, UK
    Br J Cancer 98:1176-81. 2008
    ..At the time of data collection, 56% (112 out of 200) of GP partners reported that they were aware of receiving the PCRMP pack. To ensure future, effective implementation of guidelines requires evaluation...
  4. pmc The feasibility and results of a population-based approach to evaluating prostate-specific antigen screening for prostate cancer in men with a raised familial risk
    J Melia
    Cancer Screening Evaluation Unit, Institute of Cancer Research, Brookes Lawley Building, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK
    Br J Cancer 94:499-506. 2006
    ..To study further the effects of screening, patients with a raised familial risk should be counselled in clinic about screening of relatives and data routinely recorded so that the effects of screening on high-risk groups can be studied...
  5. ncbi request reprint Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study
    Jane Melia
    Cancer Screening Evaluation Unit, Institute of Cancer Research, Sutton, Surrey, UK
    BJU Int 94:51-6. 2004
    ..To assess the rate of prostate-specific antigen (PSA) testing for prostate cancer in general practice in asymptomatic and symptomatic patients...
  6. pmc Feasibility of familial PSA screening: psychosocial issues and screening adherence
    J Sweetman
    Academic Department of Radiotherapy, Institute of Cancer Research and Royal Marsden NHS Trust, Downs Road, Sutton, Surrey SM2 5PT, UK
    Br J Cancer 94:507-12. 2006
    ..05). First-degree relatives entering the linked familial PSA screening programme do not, in general, have high levels of psychological morbidity. However, a small number of men exhibited psychological distress...
  7. ncbi request reprint Evaluation of primary prevention initiatives for skin cancer: a review from a UK perspective
    J Melia
    Cancer Screening Evaluation Unit, Section of Epidemiology, D Block, Cotswold Road, Sutton, Surrey SM2 5NG, UK
    Br J Dermatol 143:701-8. 2000
    ....
  8. pmc Problems with registration of cutaneous malignant melanoma in England
    J Melia
    Cancer Screening Evaluation Unit, Institute of Cancer Research, Sutton, Surrey, UK
    Br J Cancer 72:224-8. 1995
    ..As the skin cancer target for Health of the Nation depends on monitoring trends in the incidence of malignant melanoma, future improved ascertainment of cases and changes in the type of cases being registered must be taken into account...
  9. pmc Evaluation of bowel cancer registration data in England, 1996-2004
    A M Jones
    Cancer Screening Evaluation Unit, Institute of Cancer Research, Sutton, Surrey, UK
    Br J Cancer 101:1269-73. 2009
    ....
  10. pmc Feasibility of targeted early detection for melanoma: a population-based screening study
    J Melia
    Cancer Screening Evaluation Unit, Section of Epidemiology, Sutton, Surrey, UK
    Br J Cancer 82:1605-9. 2000
    ..Targeted screening for melanoma in the UK will be hampered by difficulties in accurately identifying the target population. Strategies to improve skin self-awareness rather than screening should be developed and evaluated...
  11. pmc The relation between mortality from malignant melanoma and early detection in the Cancer Research Campaign Mole Watcher Study
    J Melia
    Cancer Screening Evaluation Unit, Institute of Cancer Research, Section of Epidemiology, D Block, Cotswold Road, Sutton, Surrey SM2 5NG, UK
    Br J Cancer 85:803-7. 2001
    ..9-1.7) in men, 0.9 (95% Cl 0.7-1.3) in females. The lack of a significant reduction in melanoma mortality associated with the intervention raises questions about this approach to early detection and emphasises the need for new strategies...
  12. ncbi request reprint Part 1: The burden of prostate cancer, its natural history, information on the outcome of screening and estimates of ad hoc screening with particular reference to England and Wales
    Jane Melia
    Cancer Screening Evaluation Unit, Institute of Cancer Research, Sutton, Surrey, UK
    BJU Int 95:4-15. 2005
  13. pmc Performance measures in three rounds of the English bowel cancer screening pilot
    S M Moss
    Cancer Screening Evaluation Unit, Section of Epidemiology, Institute of Cancer Research, SRD Building, Cotswold Road, Sutton, Surrey SM2 5NG, UK
    Gut 61:101-7. 2012
    ..To compare performance measures across all three rounds of the English bowel cancer screening faecal occult blood test pilot and their relation to social deprivation and ethnicity...
  14. pmc Survey of the rate of PSA testing in general practice
    J Melia
    Cancer Screening Evaluation Unit, Institute of Cancer Research, Section of Epidemiology, D Block, Cotswold Road, Sutton, Surrey, SM2 5NG, UK
    Br J Cancer 85:656-7. 2001
    ..5% out of 160 015 men aged > 45 on a GP database, who had no previous record of prostate cancer, had a PSA test. Of the tested men, 21.3% had a PSA > 4 ng/ml. Future data need to distinguish between men with and without symptoms...
  15. doi request reprint A practical application of analysing weighted kappa for panels of experts and EQA schemes in pathology
    Karen C Wright
    Cancer Screening Evaluation Unit, Institute of Cancer Research, 15 Cotswold Road, Sutton, UK
    J Clin Pathol 64:257-60. 2011
    ..Weighted kappa can be used to adjust for this when comparing a small number of readers, but this has not as yet been applied to the large number of readers typical of a national EQA scheme...
  16. ncbi request reprint Introduction: Review of screening for prostate cancer
    Jane Melia
    Cancer Screening Evaluation Unit, Institute of Cancer Research, Sutton, Surrey, UK
    BJU Int 95:1-3. 2005
  17. ncbi request reprint Impact of skin cancer education on medical students' diagnostic skills
    S Cliff
    Department of Dermatology, St Helier Hospital, Carshalton, Surrey, UK
    Clin Exp Dermatol 28:214-7. 2003
    ..The methods of evaluation, such as ours, can be simple and inexpensive...
  18. doi request reprint Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study
    Anita V Mitra
    The Institute of Cancer Research, Sutton, Surrey, UK
    BJU Int 107:28-39. 2011
    ..This is the first multicentre screening study targeted at men with a known genetic predisposition to prostate cancer. A preliminary analysis of the data is reported...